Evidence map›Paper›PMID 33255164›Full record

ArticleInternational journal of environmental research and public health2020

Alternative Tobacco Product Use in Critically Ill Patients.

Tom Liu, Thomas J Deiss, Matthew W Lippi, Alejandra Jauregui, Kathryn Vessel, Serena Ke, Annika Belzer, Hanjing Zhuo, Kirsten N Kangelaris, Antonio D Gomez and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Tom LiuDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Thomas J DeissDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.ORCID 0000-0003-0972-7663
Matthew W LippiDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.ORCID 0000-0001-7637-6758
Alejandra JaureguiDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Kathryn VesselDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Serena KeDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.ORCID 0000-0002-3029-8501
Annika BelzerDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Hanjing ZhuoDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Kirsten N KangelarisDepartment of Medicine, Division of Hospital Medicine, University of California, San Francisco, CA 94143, USA.
Antonio D GomezDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Michael A MatthayDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Kathleen D LiuDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
Carolyn S CalfeeDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA.
University of California, San Francisco · USRutgers, The State University of New Jersey · USSan Francisco General Hospital · US

Funding

Training and Education p489-500P50CA180890 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2013 to 2018
$20.5M
PROJECT 5: IMPACT OF CHANGING TOBACCO PRODUCT USE ON HEALTHCARE COSTS FOR GENERAL AND VULNERABLE POPULATIONSU54HL147127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2018 to 2022
$20.4M
National Cancer Institute and Food and Drug Administration Center for Tobacco Products P50CA180890NCI NIH HHS P50 CA180890NHLBI NIH HHS U54 HL147127
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tobacco ProductsTobacco UseAgedCritical IllnessFemaleHumansMaleMiddle AgedUnited Statesalternative tobacco productscritical illnesselectronic nicotine delivery devicesnon-cigarette tobacco productssmoking-caused diseasesurveillance and monitoringsurvey research

Identifiers

PMID33255164
PMCPMC7727672
OpenAlexW3107764757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.